We are thrilled to announce that following the scientific advice meeting with The Medicines and Healthcare products Regulatory Agency in the UK, Adiposs received endorsement for its flagship product, ImageBAT, to proceed to Clinical Trials.
ImageBAT is the state-of-the-art imaging product that makes brown adipose tissue visible with a fast and pain-free CT scan. It enables early detection of body wasting before patients lose weight.
Phase I Clinical Trial is planned to start in the second half of 2021 and is meant to explore safety, tolerability and pharmacokinetics of ImageBAT and to establish the effective dose for ImageBAT-enhanced CT imaging of brown adipose tissue.
“ImageBAT has the potential to improve quality of life and outcomes in patients with cancer and chronic diseases. I am proud of the Adiposs team which has advanced it up to human clinical trials” said Dr. Andrej Babic, CEO of Adiposs.